Showing results (61-70 of 442) with videos related to

Sort By:
Pageof 45
Inflammatory Bowel Diseases|July 12, 2011
Challenges associated with identifying the environmental determinants of the inflammatory bowel diseasesNatalie A Molodecky, Remo Panaccione, Subrata Ghosh, et al.
Inflammatory Bowel Diseases|April 20, 2013
Evolving definitions of remission in Crohn's diseaseRemo Panaccione, Jean-Frédéric Colombel, Edouard Louis, et al.
Advances in Therapy|May 19, 2019
Risk of Developing Additional Immune-Mediated Manifestations: A Retrospective Matched Cohort StudyDaniel Aletaha, Andrew J Epstein, Martha Skup, et al.
Inflammatory Bowel Diseases|August 16, 2013
The increasing weight of Crohn's disease subjects in clinical trials: a hypothesis-generatings time-trend analysisGordon W Moran, Marie-France Dubeau, Gilaad G Kaplan, et al.
Digestive Diseases (Basel, Switzerland)|January 9, 2013
Deep remission: a new concept?Jean-Frédéric Colombel, Edouard Louis, Laurent Peyrin-Biroulet, et al.
Seminars in Arthritis and Rheumatism|May 31, 2022
Critical appraisal and future outlook on anti-inflammatory biosimilar use in chronic immune-mediated inflammatory diseasesStefan Schreiber, Luis Puig, João Gonçalves, et al.
Therapeutic Advances in Gastroenterology|June 12, 2020
Complementary and alternative medications in the management of inflammatory bowel diseaseSherman Picardo, Mansour Altuwaijri, Shane M Devlin, et al.
BMC Gastroenterology|September 7, 2019
Crohn's-like disease in a patient exposed to anti-Interleukin-17 blockade (Ixekizumab) for the treatment of chronic plaque psoriasis: a case reportMatthew K Smith, Jay Pai, Remo Panaccione, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 16, 2010
A pro-resolution mediator, prostaglandin D(2), is specifically up-regulated in individuals in long-term remission from ulcerative colitisLinda Vong, Jose G P Ferraz, Remo Panaccione, et al.
ACG Case Reports Journal|October 15, 2025
Refractory Immune Checkpoint Inhibitor Colitis Treated With Biologics, Janus Kinase Inhibition, Plasma Exchange, and Fecal Microbiota TransplantationJason Hearn, Getanshu Malik, Igor Stukalin, et al.
Pageof 45